Moderna climbs after saying COVID-19 vaccine generates antibodies in older adults


rose 4% in early premarket trade as it said late Tuesday that early-stage data suggests its COVID-19 vaccine can generate neutralizing antibodies in older and elderly adults at levels comparable to those in younger adults. The study was published in The New England Journal of Medicine. Moderna’s stock has surged 251% this year.

Read More

READ MORE:   Walmart will stop putting 'multicultural' products in locked cases

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button